Management of patients with concurrent clonal plasma cell and myeloid disorders: A single center descriptive case series
-
Published:2024
Issue:
Volume:22
Page:100469
-
ISSN:2213-0489
-
Container-title:Leukemia Research Reports
-
language:en
-
Short-container-title:Leukemia Research Reports
Author:
Hochman Michael J.ORCID, Gerber Gloria F., Imus Philip H., Ali Syed Abbas, DeZern Amy E.
Reference15 articles.
1. Premalignant clonal hematopoietic proliferations;Nardi;Am. J. Clin. Pathol.,2019 2. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management;Kyle;Leukemia,2010 3. The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms;Khoury;Leukemia,2022 4. P.L. Greenberg, R.M. Stone, A. Al-Kali, J.M. Bennett, U. Borate, A.M. Brunner, W. Chai-Ho, P. Curtin, C.M. de Castro, H.J. Deeg, A.E. DeZern, S. Dinner, C. Foucar, K. Gaensler, G. Garcia-Manero, E.A. Griffiths, D. Head, B.A. Jonas, S. Keel, Y. Madanat, L.J. Maness, J. Mangan, S. McCurdy, C. McMahon, B. Patel, V.V. Reddy, D.A. Sallman, R. Shallis, P.J. Shami, S. Thota, A.N. Varshavsky-Yanovsky, P. Westervelt, E. Hollinger, D.A. Shead, C. Hochstetler, N.C.C.N. Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022, J Natl Compr Canc Netw. 20 (2022) 106–117. https://doi.org/10.6004/jnccn.2022.0009. 5. Review of 1027 patients with newly diagnosed multiple myeloma;Kyle;Mayo Clin. Proc.,2003
|
|